1 David Price Evans Global Health and Infectious Diseases Research Group, University of Liverpool, Liverpool, UK derek.cocker@liverpool.ac.uk.
2 NIHR Royal Liverpool and Broadgreen Clinical Research Facility, Liverpool, UK.
3 Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
4 UK Health Security Agency, London, UK.
5 National Institute of Health Research, Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Imperial College London, London, UK.
6 David Price Evans Global Health and Infectious Diseases Research Group, University of Liverpool, Liverpool, UK.
Innovative whole system approaches to integrate research and novel technologies within patient pathways are needed to target antibiotic use, minimise healthcare associated infections, and adapt to novel pathogens, write Derek Cocker and colleagues